Date Modified

2025-06-19

Period

6/months

Report Summary

• Trial commenced on 28.11.2024 • Recruitment status: recruitment completed. • Number assessed for eligibility: Approximately 180 • Number recruited and allocated/ randomized: 158 • Date of trial completion: 28.02.2025 • Final sample size: 158 • Preliminary results suggest that there is significant efficacy and safety in hyperbaric bupivacaine compared to isobaric bupivacaine. Full analysis is pending.

Attached file